In the present study, Nrf2 overexpression was found to reduce the killing effect of the chemotherapeutic drug Ara-C on AML cells in vitro, promote tumor growth and impair DNA mismatch repair function in vivo. Here, NFE2L2 is linked to acute myeloid leukemia.